Research map: Optimal acquisition timing for perfusion imaging in dual-phase amyloid-PET: a within-patient list-mode comparison of 5-minute versus 10-minute protocols

Back to the article

Papers in this map

  1. Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain · N. Tzourio-Mazoyer · 2002 · 17057 citations · Cited by this paper
  2. Italian association of nuclear medicine molecular imaging and therapy (AIMN) practical guide on white blood cells labelling for imaging infections and inflammations: technical procedure, quality controls and national regulations · 2026 · Related
  3. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease · Clifford R. Jack · 2018 · 10916 citations · Cited by this paper
  4. Technical and clinical recommendations for [¹⁸F]FDOPA PET/CT in oncologic applications · 2026 · Related
  5. 3D Slicer as an image computing platform for the Quantitative Imaging Network · Andriy Fedorov · 2012 · 9319 citations · Cited by this paper
  6. The effect of semi-automatic segmentation approaches on semi-quantitative parameters of 68Ga-Pentixafor PET-CT in newly diagnosed multiple myeloma patients · 2026 · Related
  7. Automated anatomical labelling atlas 3 · Edmund T. Rolls · 2019 · 2149 citations · Cited by this paper
  8. [18F]fluorocholine PET/CT in primary hyperparathyroidism is costly but worth the cost · 2026 · Related
  9. Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E · Eric M. Reiman · 1996 · 1378 citations · Cited by this paper
  10. Why density really matters: advancing molecular breast imaging with sinogram-domain deep learning · 2026 · Related
  11. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET · Karl Herholz · 2002 · 846 citations · Cited by this paper
  12. The relationship between gleason score and 11c-choline pet/ct positive detection rate in prostate cancer patients with biochemical failure after radical prostatectomy: biological and methodological factors · 2025 · Related
  13. 18 F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial · Rik R. Vandenberghe · 2010 · 655 citations · Cited by this paper
  14. Technical research advances in PET radionuclide tracers for diagnosing hepatocellular carcinoma · 2026 · Related
  15. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study · Osama Sabri · 2015 · 630 citations · Cited by this paper
  16. Clinical study on bile excretion pattern of [18F]AlF-FAPI-74 and measures to eliminate its physiological uptake in the hepatobiliary system · 2025 · Related
  17. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study · Henryk Barthel · 2011 · 596 citations · Cited by this paper
  18. [99mTc]Tc-Octreotide SPECT-based radiomics analysis for predicting response in patients with neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE PRRT: a multicenter study on Ki-67 index and grade discordance · 2025 · Related
  19. Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density · Craig T Curtis · 2015 · 345 citations · Cited by this paper
  20. Radiomics in preclinical imaging: current trends and future directions · 2026 · Related
  21. Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging · Michel J. B. Koole · 2009 · 213 citations · Cited by this paper
  22. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease · David García‐García · 2012 · 123 citations · Cited by this paper
  23. Early [18F]florbetaben and [11C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease · Solveig Tiepolt · 2016 · 90 citations · Cited by this paper
  24. Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD Patients · Ara H. Rostomian · 2011 · 87 citations · Cited by this paper
  25. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [18F]-FDG PET/CT · Ian Alberts · 2021 · 69 citations · Cited by this paper
  26. Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer’s disease PET studies · Débora Elisa Peretti · 2019 · 50 citations · Cited by this paper
  27. Describing adverse events in medical inpatients using the Global Trigger Tool · Nicole Grossmann · 2019 · 33 citations · Cited by this paper
  28. Automatic quantification of ischemic injury on diffusion-weighted MRI of neonatal hypoxic ischemic encephalopathy · Keelin Murphy · 2017 · 29 citations · Cited by this paper
  29. Dual-phase [18F]florbetapir in frontotemporal dementia · M. Bilal Asghar · 2018 · 26 citations · Cited by this paper
  30. A new integrated dual time-point amyloid PET/MRI data analysis method · Diego Cecchin · 2017 · 24 citations · Cited by this paper
  31. Perspectives of the European Association of Nuclear Medicine (EANM) on early perfusion imaging in the context of amyloid PET imaging protocols · Silvia Daniela Morbelli · 2025 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)